Inverness Medical launches C diff Quik Chek test
Alere
Techlab C diff Quik Chek Complete
Inverness Medical has announced the launch of Techlab C diff Quik Chek Complete test as an in vitro diagnostic aid for Clostridium difficile associated diseases.
The Techlab C Diff Quik Chek Complete detects glutamate dehydrogenase (GDH) and C difficile toxins A and B in one assay and can be used for screening while confirming the presence of toxigenic C difficile strains.
C difficile antigen GDH is common to all strains of C difficile and has been identified as an excellent screening marker for the infection.
The test provides results in less than 30 minutes from faecal samples, enabling rapid diagnosis and initiation of appropriate patient management.
In addition, it detects toxigenic and non-toxigenic strains, including the new hyper-virulent C difficile strain BI/NAP1/027.
More stories
US clears Alere flu test
FDA okays Alere Influenza AandB Test for US market
Cardioprofiler assesses risk to save doctors time
The Alere Triage Cardioprofiler assesses patients with chest pain to quickly determine whether they are suffering acute coronary syndrome (ACS), without the need for a lengthy medical assessment.
Alere re-launches Determine point-of-care tests
Alere has re-launched its Determine portfolio of products for the accurate and rapid diagnosis of infectious diseases, including the HIV 1/2 Ag/Ab Combo test, to fit within its new brand image.
Tool enables early onset pre-eclampsia diagnosis
Alere has introduced a new diagnostic tool as an aid to the diagnosis of early onset pre-eclampsia - the Alere Triage PLGF test.
Alere test identifies severe acute kidney injury
According to a study, a point-of-care blood biomarker test for Neutrophil Gelatinase-Associated Lipocalin (NGAL) can help identify patients at risk of severe acute kidney injury (AKI) within a week.
